| Product NDC: | 66336-429 | 
| Proprietary Name: | clarithromycin | 
| Non Proprietary Name: | clarithromycin | 
| Active Ingredient(s): | 500 mg/1 & nbsp; clarithromycin | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 66336-429 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA065145 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20080101 | 
| Package NDC: | 66336-429-20 | 
| Package Description: | 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66336-429-20) | 
| NDC Code | 66336-429-20 | 
| Proprietary Name | clarithromycin | 
| Package Description | 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66336-429-20) | 
| Product NDC | 66336-429 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | clarithromycin | 
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20080101 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | CLARITHROMYCIN | 
| Strength Number | 500 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |